A Retrospective Study to Evaluate Vedolizumab in Patients with Crohn's Disease (CD) or Ulcerative Colitis (UC) Seeking Care
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Vedolizumab (Primary) ; Immunosuppressants
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2020 New trial record
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020.